BNP Paribas Financial Markets’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.2K | Buy |
4,169
+2,586
| +163% | +$33.6K | ﹤0.01% | 3419 |
|
|
2025
Q1 | $16.8K | Sell |
1,583
-1,155
| -42% | -$12.2K | ﹤0.01% | 3751 |
|
|
2024
Q4 | $46.5K | Sell |
2,738
-13,093
| -83% | -$222K | ﹤0.01% | 3607 |
|
|
2024
Q3 | $367K | Buy |
15,831
+14,330
| +955% | +$333K | ﹤0.01% | 2271 |
|
|
2024
Q2 | $36.5K | Sell |
1,501
-12,753
| -89% | -$311K | ﹤0.01% | 2851 |
|
|
2024
Q1 | $481K | Sell |
14,254
-9,005
| -39% | -$304K | ﹤0.01% | 2229 |
|
|
2023
Q4 | $733K | Buy |
23,259
+682
| +3% | +$21.5K | ﹤0.01% | 1924 |
|
|
2023
Q3 | $577K | Sell |
22,577
-6,814
| -23% | -$174K | ﹤0.01% | 2012 |
|
|
2023
Q2 | $843K | Sell |
29,391
-2,461
| -8% | -$70.6K | ﹤0.01% | 1750 |
|
|
2023
Q1 | $763K | Buy |
31,852
+6,648
| +26% | +$159K | ﹤0.01% | 1909 |
|
|
2022
Q4 | $427K | Sell |
25,204
-35,149
| -58% | -$596K | ﹤0.01% | 2047 |
|
|
2022
Q3 | $894K | Buy |
60,353
+55,310
| +1,097% | +$820K | ﹤0.01% | 1954 |
|
|
2022
Q2 | $79.4K | Buy |
5,043
+1,956
| +63% | +$30.8K | ﹤0.01% | 2792 |
|
|
2022
Q1 | $83.2K | Sell |
3,087
-8,518
| -73% | -$230K | ﹤0.01% | 2848 |
|
|
2021
Q4 | $430K | Buy |
11,605
+6,222
| +116% | +$230K | ﹤0.01% | 2454 |
|
|
2021
Q3 | $257K | Buy |
5,383
+2,711
| +101% | +$130K | ﹤0.01% | 2380 |
|
|
2021
Q2 | $90.4K | Sell |
2,672
-2,421
| -48% | -$81.9K | ﹤0.01% | 2484 |
|
|
2021
Q1 | $210K | Buy |
5,093
+2,387
| +88% | +$98.6K | ﹤0.01% | 2478 |
|
|
2020
Q4 | $117K | Sell |
2,706
-1,427
| -35% | -$61.9K | ﹤0.01% | 2489 |
|
|
2020
Q3 | $177K | Buy |
4,133
+3,637
| +733% | +$156K | ﹤0.01% | 2218 |
|
|
2020
Q2 | $23.2K | Buy |
+496
| New | +$23.2K | ﹤0.01% | 2707 |
|